Urology
Volume 72, Issue 5 , Pages 1135-1138 , November 2008

Preliminary Results of Radiation Therapy for Prostate Cancer in Human Immunodeficiency Virus–Positive Patients

  • Tracy Ng

      Affiliations

    • St. Vincent's Comprehensive Cancer Center, New York, New York
    • St. Vincent's Medical Center, New York, New York
    • New York Medical College, Valhalla, New York
    • ,
  • Nicholas F. Stein

      Affiliations

    • St. Vincent's Comprehensive Cancer Center, New York, New York
    • ,
  • Jed Kaminetsky

      Affiliations

    • New York University Medical Center, New York, New York
    • ,
  • Steven Berman

      Affiliations

    • Beth Israel Medical Center, New York, New York
    • ,
  • Hillel Y. Marans

      Affiliations

    • St. Vincent's Medical Center, New York, New York
    • Beth Israel Medical Center, New York, New York
    • ,
  • Bill McDermott

      Affiliations

    • St. Vincent's Comprehensive Cancer Center, New York, New York
    • ,
  • Anthony M. Berson

      Affiliations

    • St. Vincent's Comprehensive Cancer Center, New York, New York
    • St. Vincent's Medical Center, New York, New York
    • New York Medical College, Valhalla, New York
    • Corresponding Author InformationReprint requests: Anthony M. Berson, M.D., Department of Radiation Oncology, Saint Vincent's Comprehensive Cancer Center, 325 West 15th St., New York, NY 10011

Received 22 November 2006 ,Accepted 11 January 2008.

References 

  1. Roach PJ, Fleming C, Hagen MD. Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others?. Med Decis Making. 1988;8:132–144
  2. Gastaut JL, Cesaro P, Sobel A, et al. Progressive encephalopathy in an 82-year-old patient with HIV positive serology and prostatic cancer. Rev Neurol. 1991;147:251–257
  3. Schwartz JD, Prince D. Prostate cancer in HIV infection. AIDS. 1996;10:797–798
  4. Staiman V, Lowe FC. Prostatic disease in HIV infected patients. Infect Urol. 1996;9:42–47
  5. Levinson A, Nagler EA, Lowe FC. Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus. Urology. 2004;65:91–94
  6. O'Connor JK, Nedzi LA, Zakris EL. Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature. Clin Genitourin Cancer. 2006;5:85–88
  7. Crum NF, Hale B, Utz G, et al. Increased risk of prostate cancer in HIV infection. AIDS. 2002;16:1703–1704
  8. Huang WC, Kwon EO, Scardino PT, et al. Radical prostatectomy in patients infected with human immunodeficiency virus. BJU Int. 2006;98:303–307
  9. Quatan N, Nair S, Harrowes F. Should HIV patients be considered a high risk group for the development of prostate cancer?. Ann R Coll Surg Engl. 2005;87:437–438
  10. Manfredi R, Fulgaro C, Sabbatani S, et al. Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features: open questions for urologists, oncologists, and infectious disease specialists. Cancer Detect Prev. 2006;30:20–23
  11. Furco A, Bani-Sadr F, Guymar S, et al. Metastatic cancer of the prostate in a young 40 year-old HIV-infected patient. Presse Med. 2003;32:930–931
  12. Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005;104:1505–1511
  13. Biggar RJ, Engels EA, Ly S. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr. 2005;39:293–299
  14. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA Study. AIDS. 2002;16:1663–1671
  15. Miller NL, Bissonette EA, Bahnson R, et al. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after brachytherapy. Cancer. 2002;97:1203–1210
  16. Krupski T, Petroni GR, Bissonette EA, et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology. 2000;55:736–742
  17. Bhatnagar V, Stewart ST, Huynh V, et al. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer Prostat Dis. 2006;9:136–146
  18. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55:241–249

PII: S0090-4295(08)00063-0

doi: 10.1016/j.urology.2008.01.022

Urology
Volume 72, Issue 5 , Pages 1135-1138 , November 2008

Article Tools